CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Honey +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05427799
NCT05427799N/ACompleted
CompareCT.gov

The Influence of Daily Honey Consumption on Insulin Resistance in Obese Women With Insulin Resistance

University of Jordan·interventional·Posted Jun 22, 2022·Updated Jan 27, 2026

In Brief

A clinical study evaluating Honey and Other carbohydrate alternatives such as jell-o for Insulin Resistance. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The main objective of the study is to evaluate the effects of daily honey consumption on insulin resistance as a preventive measure against diabetes. in women with insulin resistance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Resistance
CountriesJordan
CollaboratorsAbdul Hameed Shoman Foundation

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 22, 2022
Enrollment StartMar 1, 2022
Primary CompletionMay 30, 2024
Study CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 4.0 years ago

Interventions

Honeydietary

A mixed flora honey that will be obtained from local producers. and will be consumed by a daily dose of 0.5 g/kg body weight of honey by each participant and will be divided into two doses.

Other carbohydrate alternatives such as jell-odietary

A daily dose of 0.5 g/kg body weight of Jell-O will be consumed by each participant and will be divided into two doses. Jell-O was selected as a source of sucrose with negligible phenolic capacity.